APIs for research and impurities

4-(Acetylamino)-3-bromobenzenesulfonyl chloride is a white crystalline powder that is soluble in water, ethanol and chloroform. It has an analytical standard purity of 99% or greater. This compound can be used for research and development purposes as well as for the synthesis of pharmaceuticals. The impurity profile of 4-(acetylamino)-3-bromobenzenesulfonyl chloride includes 3-acetylbenzenesulfonic acid, sodium acetate, ammonium chloride, sodium sulfite, potassium bromide, potassium iodide, potassium carbonate, and potassium citrate.

Please enquire for more information about 2,5-Dioxabicyclo[2.2.1]heptane α-D-galactopyranoside including the price, delivery time and more detailed product information at the technical inquiry form on this page

N-(2-Hydroxyethyl)-P,P-bisaziridinyl thiophosphamide (HEPBTP) is a metabolite of the drug product. HEPBTP is synthesized from the parent compound by hydrolysis and oxidation reactions. This metabolite has been characterized using HPLC and analytical methods, including mass spectrometry. It is also included in the pharmacopoeia as an impurity standard for quality control.

Bensulide is a potent inhibitor of kinases, which are enzymes that regulate various cellular processes. It has been shown to have anticancer properties by inducing apoptosis in cancer cells. Bensulide is a Chinese medicinal herb that has been used for centuries as a traditional medicine. It is an analog of protein kinase inhibitors and can be used as an inhibitor of tumor growth. Bensulide has also been found in human urine and may have potential as a diagnostic marker for cancer. Its mechanism of action involves the inhibition of protein kinases, which are involved in cell signaling pathways that regulate cell growth and division. Overall, Bensulide shows great promise as an anticancer agent with potent inhibitory effects on cancer cells.

Alpha-[4-(2-dimethylaminoethoxy)phenyl]stilbene (DS) is a synthetic, analytical standard that is used as an impurity in the manufacture of pharmaceutical products. DS is also sold as a reference material for HPLC and GC/MS analysis.

AAK1-IN-1 is a potent inhibitor of the AAK1 kinase, which plays a crucial role in regulating cell cycle progression and apoptosis. This inhibitor has shown promising results in pre-clinical studies for the treatment of cancer, particularly leukemia. AAK1-IN-1 has been found to effectively inhibit the growth of human cancer cell lines and Chinese medicinal tumor cells by blocking the activity of AAK1 kinase. This protein is involved in several cellular processes, including signal transduction pathways and protein trafficking, making it an attractive target for cancer therapy. The use of AAK1-IN-1 as a novel kinase inhibitor may offer new opportunities for developing effective treatments against various types of cancer.

Please enquire for more information about 3,5-Diiodo-4-hydroxy-DL-phenyllactic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Cefdinir impurity H is a metabolite of the drug cefdinir. It is an impurity in the drug product that was discovered during research and development of cefdinir. Cefdinir impurity H has a CAS number, which indicates that it is a drug product. It also has high purity and can be used for analytical purposes or as a metabolism study standard. Metabolism studies have been conducted on this compound to determine its pharmacological effects. This metabolite is not natural, but synthetic and may be considered a niche compound due to its limited use in research and development.br>
This impurity may be found in the form of an HPLC standard and can be used for developing new drugs against bacterial infections such as tuberculosis, which are caused by Mycobacterium tuberculosis.br>br>